Tumour heterogeneity in molecular imaging for breast cancer

被引：1
|
作者：
Lobo-Martins, S. [1 ]
Agostinetto, E. [1 ]
de Azambuja, E. [1 ,2 ]
Gebhart, G. [3 ]
机构：
[1] Univ Libre Bruxelles ULB, Hop Univ Bruxelles HUB, Inst Jules Bordet, Acad Trials Promoting Team, Brussels, Belgium
[2] Univ Libre Bruxelles ULB, Hop Univ Bruxelles HUB, Inst Jules Bordet, Med Oncol Dept, Brussels, Belgium
[3] Univ Libre Bruxelles ULB, Hop Univ Bruxelles HUB, Inst Jules Bordet, Nucl Med, Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷 / 11期
关键词：
T-DM1;
D O I：
10.1016/j.annonc.2024.07.726
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1061 / 1062
页数：2
相关论文
共 50 条
  • [41] Multimodality cellular and molecular imaging of concomitant tumour enhancement in a syngeneic mouse model of breast cancer metastasis
    Katie M. Parkins
    Veronica P. Dubois
    Amanda M. Hamilton
    Ashley V. Makela
    John A. Ronald
    Paula J. Foster
    Scientific Reports, 8
  • [42] Molecular subtype influences the magnetic resonance imaging and sonography for estimating tumour size in primary breast cancer
    Wu, Y.
    Lai, H.
    Wu, H.
    Kuo, S.
    Chien, D.
    Chien, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S60 - S60
  • [43] Multimodality cellular and molecular imaging of concomitant tumour enhancement in a syngeneic mouse model of breast cancer metastasis
    Parkins, Katie M.
    Dubois, Veronica P.
    Hamilton, Amanda M.
    Makela, Ashley V.
    Ronald, John A.
    Foster, Paula J.
    SCIENTIFIC REPORTS, 2018, 8
  • [44] The future of breast cancer diagnosis: Molecular breast imaging
    Brem, RF
    MAYO CLINIC PROCEEDINGS, 2005, 80 (01) : 17 - 18
  • [45] Molecular pathways and molecular imaging in breast cancer: An update
    Cervino, Anna Rita
    Burei, Marta
    Mansi, Luigi
    Evangelista, Laura
    NUCLEAR MEDICINE AND BIOLOGY, 2013, 40 (05) : 581 - 591
  • [46] Molecular Imaging of Breast Cancer: Visualizing In Vivo Breast Cancer Biology
    Mankoff, D. A.
    Chodosh, L. A.
    CANCER RESEARCH, 2012, 72
  • [47] Revealing tumour spatial heterogeneity in breast cancer and the impact on clinical management.
    Bayani, Jane
    Trinh, Quang M.
    Quintayo, Mary Anne
    Crozier, Cheryl
    Hopkins, Megan
    Qiao, Jingping
    Cheung, Alison
    Mainprize, James G.
    Morris, Quaid
    Spears, Melanie
    Yaffe, Martin J.
    Stein, Lincoln D.
    Bartlett, John M. S.
    CANCER RESEARCH, 2020, 80 (21)
  • [48] Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance
    Althobiti, Maryam
    Aleskandarany, Mohammed A.
    Joseph, Chitra
    Toss, Michael
    Mongan, Nigel
    Diez-Rodriguez, Maria
    Nolan, Christopher C.
    Ashankyty, Ibraheem
    Ellis, Ian O.
    Green, Andrew R.
    Rakha, Emad A.
    HISTOPATHOLOGY, 2018, 73 (06) : 887 - 896
  • [49] Exploring breast cancer heterogeneity in the context of metastatic tumour microenvironments and therapy resistance
    Gadipally, Sreeja Reddy
    Berthelet, Jean
    Lee, Samuel C.
    Bhuva, Dharmesh D.
    Roach, Michael
    El-Saafin, Farrah
    Bell, Caroline
    Wu, Yunjian
    Baloyan, David
    Ginestier, Christphe
    Emmanuelle, Charafe Jauffret
    Davis, Melissa
    Anderson, Robin L.
    Martelotto, Luciano
    Yeo, Belinda
    Merino, Delphine
    CANCER RESEARCH, 2024, 84 (22)
  • [50] Impact of tumour heterogeneity on the robustness of Ki67 scoring in breast cancer
    Nijenhuis, M. V.
    Drukker, C. A.
    Sanders, J.
    Linn, S. C.
    Rutgers, E. J. T.
    Wesseling, J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S194 - S194
12345